224 related articles for article (PubMed ID: 24004000)
1. Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit.
Lynch RW; Lowe D; Protheroe A; Driscoll R; Rhodes JM; Arnott ID
Aliment Pharmacol Ther; 2013 Oct; 38(8):935-45. PubMed ID: 24004000
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.
Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Vuitton L; Moreau J; Amiot A; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Fumery M; Carbonnel F; Bommelaer G; Coffin B; Roblin X; van Assche G; Esteve M; Farkkila M; Gisbert JP; Marteau P; Nahon S; de Vos M; Lambert J; Mary JY; Louis E;
Gut; 2018 Feb; 67(2):237-243. PubMed ID: 28053054
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
[TBL] [Abstract][Full Text] [Related]
4. Surgical outcomes in steroid refractory acute severe ulcerative colitis: the impact of rescue therapy.
Powar MP; Martin P; Croft AR; Walsh A; Petersen D; Stevenson AR; Lumley JW; Stitz RW; Radford-Smith GL; Clark DA
Colorectal Dis; 2013 Mar; 15(3):374-9. PubMed ID: 22849324
[TBL] [Abstract][Full Text] [Related]
5. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
[TBL] [Abstract][Full Text] [Related]
6. Improved Medical Treatment and Surgical Surveillance of Children and Adolescents with Ulcerative Colitis in the United Kingdom.
Auth MK; Bunn SK; Protheroe AL; Williams LJ; Fell JM; Muhammed R; Croft NM; Beattie RM; Willmott A; Spray C; Vadamalayan B; Rodrigues A; Puntis J; Pigott AJ; Wilson DC; Mitton S; Furman M; Charlton C; Chong SKF; ; ; Russell RK
Inflamm Bowel Dis; 2018 Jun; 24(7):1520-1530. PubMed ID: 29668982
[TBL] [Abstract][Full Text] [Related]
7. Review article: the practical management of acute severe ulcerative colitis.
Seah D; De Cruz P
Aliment Pharmacol Ther; 2016 Feb; 43(4):482-513. PubMed ID: 26725569
[TBL] [Abstract][Full Text] [Related]
8. Outcome of a conservative approach in severe ulcerative colitis.
Daperno M; Sostegni R; Scaglione N; Ercole E; Rigazio C; Rocca R; Pera A
Dig Liver Dis; 2004 Jan; 36(1):21-8. PubMed ID: 14971812
[TBL] [Abstract][Full Text] [Related]
9. Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT).
Seagrove AC; Alam MF; Alrubaiy L; Cheung WY; Clement C; Cohen D; Grey M; Hilton M; Hutchings H; Morgan J; Rapport F; Roberts SE; Russell D; Russell I; Thomas L; Thorne K; Watkins A; Williams JG
BMJ Open; 2014 Apr; 4(4):e005091. PubMed ID: 24785401
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
Croft A; Walsh A; Doecke J; Cooley R; Howlett M; Radford-Smith G
Aliment Pharmacol Ther; 2013 Aug; 38(3):294-302. PubMed ID: 23786158
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
Ordás I; Domènech E; Mañosa M; García-Sánchez V; Iglesias-Flores E; Peñalva M; Cañas-Ventura A; Merino O; Fernández-Bañares F; Gomollón F; Vera M; Gutiérrez A; Garcia-Planella E; Chaparro M; Aguas M; Gento E; Muñoz F; Aguirresarobe M; Muñoz C; Fernández L; Calvet X; Jiménez CE; Montoro MA; Mir A; De Castro ML; García-Sepulcre MF; Bermejo F; Panés J; Esteve M
Am J Gastroenterol; 2017 Nov; 112(11):1709-1718. PubMed ID: 28675163
[TBL] [Abstract][Full Text] [Related]
12. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial.
Williams JG; Alam MF; Alrubaiy L; Arnott I; Clement C; Cohen D; Gordon JN; Hawthorne AB; Hilton M; Hutchings HA; Jawhari AU; Longo M; Mansfield J; Morgan JM; Rapport F; Seagrove AC; Sebastian S; Shaw I; Travis SP; Watkins A
Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):15-24. PubMed ID: 27595142
[TBL] [Abstract][Full Text] [Related]
13. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Nachury M; Moreau J; Delchier JC; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Dupas JL; Carbonnel F; Bommelaer G; Coffin B; Roblin X; Van Assche G; Esteve M; Färkkilä M; Gisbert JP; Marteau P; Nahon S; de Vos M; Franchimont D; Mary JY; Colombel JF; Lémann M;
Lancet; 2012 Dec; 380(9857):1909-15. PubMed ID: 23063316
[TBL] [Abstract][Full Text] [Related]
14. Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review.
Gisbert JP; García MJ; Chaparro M
J Crohns Colitis; 2023 Jun; 17(6):972-994. PubMed ID: 36652279
[TBL] [Abstract][Full Text] [Related]
15. Short- and Long-Term Outcomes of Acute Severe Ulcerative Colitis in Korea: The 1999-2005 Cohort.
Lee HS; Yang SK; Soh JS; Lee S; Bae JH; Lee HJ; Park SH; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
Inflamm Bowel Dis; 2015 Aug; 21(8):1825-31. PubMed ID: 25985248
[TBL] [Abstract][Full Text] [Related]
16. Early colectomy in steroid-refractory acute severe ulcerative colitis improves operative outcome.
Saha SK; Panwar R; Kumar A; Pal S; Ahuja V; Dash NR; Makharia G; Sahni P
Int J Colorectal Dis; 2018 Jan; 33(1):79-82. PubMed ID: 28920181
[TBL] [Abstract][Full Text] [Related]
17. Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patients.
Costello SP; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; O'Connor S; Connor SJ; Sparrow MP; Bampton P; Walsh AJ; Andrews JM;
Intern Med J; 2015 Jun; 45(6):659-66. PubMed ID: 25732268
[TBL] [Abstract][Full Text] [Related]
18. Predicting the Course of Disease in Hospitalized Patients With Acute Severe Ulcerative Colitis.
Bernardo S; Fernandes SR; Gonçalves AR; Valente A; Baldaia C; Santos PM; Correia LA
Inflamm Bowel Dis; 2019 Feb; 25(3):541-546. PubMed ID: 30085135
[TBL] [Abstract][Full Text] [Related]
19. Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
Weisshof R; Ollech JE; El Jurdi K; Yvellez OV; Cohen RD; Sakuraba A; Dalal S; Pekow J; Rubin DT
J Crohns Colitis; 2019 Sep; 13(9):1105-1110. PubMed ID: 30726894
[TBL] [Abstract][Full Text] [Related]
20. Colonic MicroRNA Profiles, Identified by a Deep Learning Algorithm, That Predict Responses to Therapy of Patients With Acute Severe Ulcerative Colitis.
Morilla I; Uzzan M; Laharie D; Cazals-Hatem D; Denost Q; Daniel F; Belleannee G; Bouhnik Y; Wainrib G; Panis Y; Ogier-Denis E; Treton X
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):905-913. PubMed ID: 30223112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
